Zhitong Finance App News, Taiji Group (600129.SH) issued an announcement. Recently, Southwest Pharmaceutical Co., Ltd., a holding subsidiary of the company, received a “Drug Registration Certificate” for butorphinol tartrate injection issued by the State Drug Administration. This drug is suitable for treating all kinds of cancer pain and pain after surgery. The drug has obtained the “Drug Registration Certificate” and is considered to have passed the consistent evaluation of the quality and efficacy of generic drugs, which will further enrich the company's product line.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.